found little difference potency antibodies generated 20 participants viruses carrying n501y mutation compared viruses lacking change team examining effects mutations variants related experiment team led colleague menachery found 501y mutation not drastically affect activity neutralizing antibodies convalescent serum antibody containing portion blood taken people recovered covid infection suggests 501y mutation unlikely alter immunity adds menachery posted data 22 december mutations prime receptor binding domain mutation de oliveira team identified 501y.v2 variant called e484k. team working virologist alex sigal africa health research institute durban test variant convalescent serum serum people vaccinated trials results studies public days says de oliveira emerging evidence